Malignant gliomas: Perverting glutamate and ion homeostasis for selective advantage

Trends in Neurosciences

Volumn 26, Issue 10, 2003, Pages 543-549

  Sontheimer, Harald ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYPHENYLGLYCINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; GLUTAMIC ACID; ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; [1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID;

AUTOCRINE EFFECT; AUTOPSY; CANCER INVASION; CELL INVASION; GLIOBLASTOMA; HOMEOSTASIS; HUMAN; METASTASIS; MORPHOLOGY; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; ONCOGENE; PRIORITY JOURNAL; REVIEW; SKULL; SPINE; STEM CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WORLD HEALTH ORGANIZATION;

EID: 0141533202     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2003.08.007     Document Type: Review

References (61)

1. Linskey M.E. Glial ontogeny and glial neoplasia: the search for closure. J. Neurooncol. 34:1997;5-22.
2. Louis D.N. The p53 gene and protein in human brain tumors. J. Neuropathol. Exp. Neurol. 53:1994;11-21.
3. Von Deimling A., et al. Molecular pathways in the formation of gliomas. Glia. 15:1995;328-338.
4. Shapiro J.R. Genetics of brain neoplasms. Curr. Neurol. Neurosci. Rep. 1:2001;217-224.
5. Maher E.A., et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15:2001;1311-1333.
6. Holland E.C., et al. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 12:1998;3675-3685.
7. Tang P., et al. The autocrine loop of TGF-α/EGFR and brain tumors. J. Neurooncol. 35:1997;303-314.
8. Plate K.H., Risau W. Angiogenesis in malignant gliomas. Glia. 15:1995;339-347.
9. Ye Z.C., Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res. 59:1999;4383-4391.
10. Takano T., et al. Glutamate release promotes growth of malignant gliomas. Nat. Med. 7:2001;1010-1015.
11. Laerum O.D., et al. Invasiveness of primary brain tumors. Cancer Metastasis Rev. 3:1984;223-236.
12. Merzak A., Pilkington G.J. Molecular and cellular pathology of intrinsic brain tumors. Cancer Metastasis Rev. 16:1997;155-177.
13. 1. Br. J. Cancer. 70:1994;199-203.
14. Kaba S.E., Kyritsis A.P. Recognition and management of gliomas. Drugs. 53:1997;235-244.
15. Ojemann J.G., et al. Preserved function in brain invaded by tumor. Neurosurgery. 39:1996;253-258.
16. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65:2001;1-105.
17. Rothstein J.D. Excitotoxicity hypothesis. Neurology. 47:1996;S19-S25.
18. Olney J.W. New mechanisms of excitatory transmitter neurotoxicity. J. Neural Transm. Suppl. 43:1994;47-51.
19. Araque A., et al. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 22:1999;208-215.
20. Rothstein J.D., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 16:1996;675-686.
21. Tanaka K., et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter Glt-1. Science. 276:1997;1699-1702.
22. Ye Z.C., et al. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J. Neurosci. 19:1999;10767-10777.
23. Sato H., et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274:1999;11455-11458.
24. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
25. Pitt D., et al. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6:2000;67-70.
26. Kim J.Y., et al. Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim. Biophys. Acta. 1512:2001;335-344.
27. Iida M., et al. Effect of glutathione-modulating compounds on hydrogen-peroxide-induced cytotoxicity in human glioblastoma and glioma cell lines. J. Cancer Res. Clin. Oncol. 123:1997;619-622.
28. Oberndorfer S., et al. The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wien. Klin. Wochenschr. 114:2002;911-916.
29. Behrens P.F., et al. Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study. J. Neurooncol. 47:2000;11-22.
30. Giese A., et al. Determinants of human astrocytoma migration. Cancer Res. 54:1994;3897-3904.
31. Thorsen F., Tysnes B.B. Brain tumor cell invasion, anatomical and biological considerations. Anticancer Res. 17:1997;4121-4126.
32. Nakada M., et al. The role of matrix metalloproteinases in glioma invasion. Front. Biosci. 8:2003;E261-E269.
33. Lakka S.S., et al. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene. 21:2002;8011-8019.
34. + ion channel blockers. J. Neurosci. 19:1999;5942-5954.
35. Noctor S.C., et al. Dividing precursor cells of the embryonic cortical ventricular zone have morphological and molecular characteristics of radial glia. J. Neurosci. 22:2002;3161-3173.
36. Ransom C.B., et al. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J. Neurosci. 21:2001;7674-7683.
37. Bordey A., et al. Muscarinic activation of BK channels induces membrane oscillations in glioma cells and leads to inhibition of cell migration. J. Membr. Biol. 176:2000;31-40.
38. Jackson P.S., Strange K. Characterization of the voltage-dependent properties of a volume-sensitive anion conductance. J. Gen. Physiol. 105:1995;661-676.
39. Jackson P.S., Strange K. Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux. Am. J. Physiol. 265:1993;C1489-C1500.
40. Bakhramov A., et al. Chloride current activated by hypotonicity in cultured human astrocytoma cells. Exp. Physiol. 80:1995;373-389.
41. Rouzaire-Dubois B., et al. Evidence for several mechanisms of volume regulation in neuroblastoma×glioma hybrid NG108-15 cells. Neuroscience. 88:1999;307-317.
42. Ullrich N., et al. Expression of voltage-activated chloride currents in acute slices of human gliomas. Neuroscience. 83:1998;1161-1173.
43. Olsen, M.L. et al. Expression of voltage-gated chloride channels in human glioma cells. J. Neurosci. (in press).
44. A receptors on human glioma cells. Eur. J. Neurosci. 10:1998;231-238.
45. 2+ signalling, protein tyrosine phosphorylation and MAP kinase in regulatory volume decrease. J. Physiol. 537:2001;2-62.
46. Duffy S.M., et al. Voltage-dependent and calcium-activated ion channels in the human mast cell line HMC-1. J. Leukoc. Biol. 70:2001;233-240.
47. Chou C.Y., et al. Volume-sensitive chloride channels associated with human cervical carcinogenesis. Cancer Res. 55:1995;6077-6083.
48. + currents. Br. J. Pharmacol. 127:1999;1819-1831.
49. Levison S.W., et al. The migrational patterns and developmental fates of glial precursors in the rat subventricular zone are temporally regulated. Development. 119:1993;611-622.
50. Amberger V.R., et al. Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin. Eur. J. Neurosci. 9:1997;151-162.
51. Simpson P.B., Armstrong R.C. Intracellular signals and cytoskeletal elements involved in oligodendrocyte progenitor migration. Glia. 26:1999;22-35.
52. Alvarez-Buylla A., et al. The subventricular zone: source of neuronal precursors for brain repair. Prog. Brain Res. 127:2000;1-11.
53. LoTurco J.J., et al. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron. 15:1995;1287-1298.
54. Andersen P., et al. Two different responses of hippocampal pyramidal cells to application of gamma-amino butyric acid. J. Physiol. 305:1980;279-296.
55. Walz W. Chloride/anion channels in glial cell membranes. Glia. 40:2002;1-10.
56. Kimelberg H.K. Current concepts of brain edema. J. Neurosurg. 83:1995;1051-1059.
57. Rakic P., Komuro H. The role of receptor/channel activity in neuronal cell migration. J. Neurobiol. 26:1995;299-315.
58. Bordey A., et al. Muscarinic activation of bk channels induces membrane oscillations in glioma cells and leads to inhibition of cell migration. J. Membr. Biol. 176:2000;31-40.
59. 2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat. Med. 8:2002;971-978.
60. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron. 12:1994;1281-1289.
61. Kleihues P., et al. Histopathology, classification and grading of gliomas. Glia. 15:1995;211-221.